ZCA
RGEN icon

Zeke Capital Advisors’s Repligen RGEN Stock Holding History

Zeke Capital Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,455
Closed -$236K – 494
2022
Q2 		$236K Buy
1,455
+314
+28% +$49.7K 0.02% 404
2022
Q1 		$215K Buy
+1,141
New +$217K 0.01% 464

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Zeke Capital Advisors's RGEN Position: Q3 2022 in Review

Zeke Capital Advisors sold out of Repligen (RGEN) in Q3 2022, closing a stake of 1,455 shares — an estimated $236K sold.

Zeke Capital Advisors first reported a position in RGEN in Q1 2022 and held it in 2 quarters. The position peaked at $236K in Q2 2022. 434 funds tracked by Wall St. Rank hold RGEN as of Q3 2022.

  • Zeke Capital Advisors reported no remaining Repligen position as of Q3 2022 after selling out during the quarter.
  • Zeke Capital Advisors sold 1,455 Repligen shares in Q3 2022, an estimated $236K.
  • Zeke Capital Advisors first reported a position in Repligen in Q1 2022 and held it in 2 quarters.
  • Zeke Capital Advisors's Repligen position peaked at $236K in Q2 2022.
  • 434 funds tracked by Wall St. Rank held Repligen as of Q3 2022.

Based on Zeke Capital Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.